Ceftaroline Fosamil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 670 publications
Ceftaroline and ceftobiprole monotherapy for the treatment of Staphylococcus aureus infections: a systematic review and Bayesian meta-analysis.
Journal: The Journal of antimicrobial chemotherapy
Published: May 05, 2026
Single point mutations in global regulatory genes restore cephalosporin resistance in a low-MIC Enterococcus faecium natural isolate.
Journal: Antimicrobial agents and chemotherapy
Published: March 23, 2026
Clinical Experience of Ceftaroline Fosamil in Gram-Positive Infective Endocarditis: A Multicenter Real-World Observational Study.
Journal: Antibiotics (Basel, Switzerland)
Published: March 23, 2026
Impact of extracorporeal membrane oxygenation on antimicrobial exposure in critically ill patients: a prospective observational study.
Journal: Critical care (London, England)
Published: February 25, 2026
Inference of ceftobiprole susceptibility through surrogate testing of ceftaroline.
Journal: Journal of clinical microbiology
Published: February 24, 2026
Comparative effectiveness of ceftaroline plus vancomycin or daptomycin versus vancomycin or daptomycin monotherapy for MRSA bacteremia: an updated systematic review and meta-analysis.
Journal: Expert review of anti-infective therapy
Published: January 29, 2026
Plasma and parasternal subcutaneous tissue pharmacokinetics of ceftaroline fosamil in cardiac surgery with cardiopulmonary bypass.
Journal: Frontiers in pharmacology
Published: January 28, 2026
Beyond mecA: a two-tiered mechanism and regulatory rewiring drive high-level ceftaroline resistance in clinical MRSA.
Journal: Antimicrobial agents and chemotherapy
Published: January 07, 2026
Sodium load of novel antibiotics: considerations for nephrologists and clinicians.
Journal: International urology and nephrology
Published: November 19, 2025
In vitro and in vivo activity of daptomycin plus ceftaroline for the treatment of experimental endocarditis due to Enterococcus faecalis with and without high-level aminoglycoside resistance.
Journal: The Journal of antimicrobial chemotherapy
Published: November 12, 2025
Last Updated: 09/26/2026